Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription injectable medication used to treat anemia associated with chronic kidney disease (CKD). It stimulates red blood cell production, helping improve hemoglobin levels and reduce fatigue. Provided in a pre-filled syringe for precise dosing and convenient administration under medical supervision.

Key Features:

• Active ingredient: Methoxy polyethylene glycol-epoetin beta 100mcg per 0.3ml syringe.
• Treats anemia in patients with chronic kidney disease, both on dialysis and non-dialysis.
• Pre-filled syringe ensures accurate dosing and ease of use.
• Extended half-life allows less frequent dosing compared to conventional erythropoiesis-stimulating agents (ESAs).
• Administered subcutaneously under physician guidance.

Recommended Usage:

• Dosage and frequency are determined by a healthcare provider based on hemoglobin levels and patient response.
• Inject subcutaneously, rotating injection sites as advised.
• Regular blood monitoring is necessary to prevent excessive hemoglobin increase.
• Not for use in patients with uncontrolled hypertension or known hypersensitivity to the active ingredient.
• Store in a refrigerator at 2–8°C and do not freeze. Protect from light.